- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Di | BPC Instruments AB: BPC Instruments expands into the textile sector - receives order from a global materials company | 160 | PR Newswire | LUND, Sweden, Sept. 2, 2025 /PRNewswire/ -- BPC Instruments AB (publ) is extending the industrial application of its BPC® Blue platform into the textiles & apparel sector, broadening the... ► Artikel lesen | |
| 27.08. | BPC Instruments AB: BPC Instruments reports results for H1 and Q2 2025 | 397 | PR Newswire | LUND, Sweden, Aug. 27, 2025 /PRNewswire/ -- BPC Instruments (publ) hereby publishes the half-year report for the period January 1 - June 30, 2025. The half-year report is available as an... ► Artikel lesen | |
| 05.08. | BPC Instruments AB: BPC Instruments secures 4.4 MSEK order from a public research organisation in the Philippines | 293 | PR Newswire | LUND, Sweden, Aug. 5, 2025 /PRNewswire/ -- BPC Instruments AB (publ) has received an order valued at approximately SEK 4.4 million from a public research institution in the Philippines, operating... ► Artikel lesen | |
| 21.07. | BPC Instruments AB: BPC Instruments receives order from Cornell University of 1 MSEK | 230 | PR Newswire | LUND, Sweden, July 21, 2025
/PRNewswire/ -- BPC Instruments AB (publ) has received an order from Cornell University in the United States valued at approximately SEK 1 million. The order... ► Artikel lesen | |
| BPC INSTRUMENTS Aktie jetzt für 0€ handeln | |||||
| 04.06. | BPC Instruments AB: BPC Instruments receives orders from KU Leuven valued at 0.7 MSEK | 278 | PR Newswire | LUND, Sweden, June 4, 2025 /PRNewswire/ -- BPC Instruments AB (publ) ("BPC") announces orders from KU Leuven university in Belgium. The orders include the delivery of several instruments... ► Artikel lesen | |
| 28.05. | Bulletin from the Annual General Meeting of BPC Instruments AB | 1 | Cision News | ||
| 23.05. | BPC INSTRUMENTS AB: Flagging in BPC Instruments | 1 | Cision News | ||
| 07.05. | BPC Instruments AB: BPC Instruments Annual Report for 2024 | 730 | PR Newswire | LUND, Sweden, May 7, 2025 /PRNewswire/ -- BPC Instruments (publ) hereby publishes the Annual Report for the year 2024. The Annual Report is available as an attached file to this release and... ► Artikel lesen | |
| 07.05. | BPC Instruments AB: BPC Instruments reports results for Q1 2025 | 576 | PR Newswire | LUND, Sweden, May 7, 2025 /PRNewswire/ -- BPC Instruments (publ) hereby publishes the interim report for the period January 1 - March 31, 2025. The interim report is available as an attachment... ► Artikel lesen | |
| 24.04. | Notice of Annual General Meeting in BPC Instruments AB (publ) | 1 | Cision News | ||
| 10.04. | BPC INSTRUMENTS AB: BPC Instruments appoints new CFO | 1 | Cision News | ||
| 26.02. | BPC Instruments AB: BPC Instruments reports result for year 2024 | 579 | PR Newswire | LUND, Sweden, Feb. 26, 2025 /PRNewswire/ -- BPC Instruments (publ) hereby publishes the year-end report for the year 2024. The year-end report is available as an attached file to this release... ► Artikel lesen | |
| 26.02. | BPC Instruments AB: BPC Instruments reports result for year 2024 | 358 | PR Newswire |
LUND, Sweden, Feb. 26, 2025 /PRNewswire/ -- BPC Instruments (publ) hereby publishes the year-end report for the year 2024. The year-end report is available as... ► Artikel lesen | |
| 20.02. | BPC Instruments AB: BPC Instruments receives order from DairyExperts for animal nutrition research | 446 | PR Newswire | LUND, Sweden, Feb. 20, 2025 /PRNewswire/ -- BPC Instruments AB (publ) ("BPC") announces an order of approx. SEK 0.5 million from DairyExperts, a US-based organisation specialising in livestock... ► Artikel lesen | |
| 24.01. | BPC Instruments AB: BPC announces Directed Share Issue to Eiffel Investment Group | 534 | PR Newswire | NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH... ► Artikel lesen | |
| 20.12.24 | BPC Instruments AB: Berenberg acquires shares in BPC | 680 | PR Newswire | LUND, Sweden, Dec. 20, 2024 /PRNewswire/ -- BPC Instruments AB (publ) ("BPC") announces that the Berenberg European Micro Cap Fund has acquired 4.8 percent of outstanding shares in BPC via... ► Artikel lesen | |
| 12.12.24 | BPC Instruments AB: BPC Instruments receives orders of 1,1 MSEK for newly launched BPC Air | 728 | PR Newswire | LUND, Sweden, Dec. 12, 2024 /PRNewswire/ -- BPC Instruments AB (publ) ("BPC") is pleased to announce orders from KTH Sweden and University of Texas USA, totaling 1,1 MSEK. These orders include... ► Artikel lesen | |
| 14.11.24 | BPC Instruments AB: BPC Instruments reports results for the period January - September 2024 | 1.113 | PR Newswire | LUND, Sweden, Nov. 14, 2024 /PRNewswire/ -- BPC Instruments (publ) hereby publishes the interim report for the period January 1-September 30, 2024. The interim report is available as an attached... ► Artikel lesen | |
| 23.09.24 | BPC Instruments AB: BPC Instruments launches the BPC Titan - a new solution for gas flow and volume monitoring in pilot and small scales fermentation processes | 861 | PR Newswire | LUND, Sweden, Sept. 23, 2024 /PRNewswire/ -- BPC Instruments AB (publ) ("BPC") announces the global launch of its latest innovation, the BPC Titan, specifically designed for biological fermentation... ► Artikel lesen |
19 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| MINERALYS THERAPEUTICS | 28,860 | 0,00 % | Mineralys Therapeutics prices upsized $250M stock offering | ||
| AVIDITY BIOSCIENCES | 47,230 | 0,00 % | Avidity Biosciences, Inc.: Avidity Biosciences Reports Second Quarter 2025 Financial Results and Recent Highlights | Aligned with FDA on del-brax accelerated and full approval pathways for FSHD, reported positive topline data from Phase 1/2 FORTITUDE trial, and initiated global... ► Artikel lesen | |
| KYMERA THERAPEUTICS | 40,690 | 0,00 % | Kymera Therapeutics, Inc.: Kymera Therapeutics Announces Second Quarter 2025 Financial Results and Provides a Business Update |
Reported positive KT-621 (STAT6) Phase 1 healthy volunteer data surpassing Kymera's target product profile, and further validating its oral, dupilumab-like profile KT-621 BroADen Phase 1b trial... ► Artikel lesen | |
| ADMA BIOLOGICS | 17,200 | 0,00 % | ADMA Biologics, Inc.: ADMA Biologics Announces Second Quarter 2025 Financial Results and Provides Business Update | 2Q 2025 Total Revenue of $122.0 Million, a 14% YoY Increase, and a 29% YoY Increase Excluding a Prior Year Non-Recurring Item 2Q 2025 GAAP Net Income of $34.2 Million, a 7% YoY Increase 2Q 2025 Adjusted... ► Artikel lesen | |
| ARCELLX | 69,75 | 0,00 % | Arcellx, Inc. (ACLX) Reports 97% Response Rate in CAR-T Trial | ||
| TARSUS PHARMACEUTICALS | 58,59 | 0,00 % | Tarsus Pharmaceuticals, Inc: Tarsus Reports Second Quarter 2025 Financial Results and Recent Business Achievements | Record quarterly net product sales of $102.7 million achieved within two years of our XDEMVY® launch, an increase of 152% year over year Direct-To-Consumer campaign has activated new patients, expanded... ► Artikel lesen | |
| SUMMIT THERAPEUTICS | 23,840 | 0,00 % | H.C. Wainwright hebt Kursziel für Summit Therapeutics auf 50 US-Dollar an | ||
| TREVI THERAPEUTICS | 7,270 | 0,00 % | Trevi Therapeutics, Inc.: Trevi Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Updates | Announced positive topline results from its Phase 2b CORAL trial of Haduvio for the treatment of chronic cough in patients with IPF
Closed $115 million underwritten... ► Artikel lesen | |
| NUVALENT | 76,90 | 0,00 % | Nuvalent, Inc.: Nuvalent Highlights Pipeline and Business Achievements, Reiterates Key Anticipated Milestones, and Reports Second Quarter 2025 Financial Results | Initiated rolling NDA submission for zidesamtinib for TKI pre-treated patients with advanced ROS1-positive NSCLC, with target completion in the third quarter of... ► Artikel lesen | |
| PRAXIS PRECISION MEDICINES | 44,940 | 0,00 % | Praxis Precision Medicines, Inc.: Praxis Precision Medicines to Participate in Upcoming Fireside Chat | ||
| UPSTREAM BIO | 20,260 | 0,00 % | Upstream Bio, Inc. - 8-K, Current Report | ||
| RECURSION PHARMACEUTICALS | 4,660 | 0,00 % | If You'd Invested $1,000 in Recursion Pharmaceuticals 4 Years Ago, Here's How Much You'd Have Today | ||
| CG ONCOLOGY | 27,460 | 0,00 % | CG Oncology Inc.: CG Oncology Reports Second Quarter 2025 Financial Results and Provides Business Updates | - Announced best-in-disease durability data in BOND-003 Cohort C and promising early signal in Cohort P for cretostimogene grenadenorepvec at the American Urological Association Annual Meeting - ... ► Artikel lesen | |
| BEAM THERAPEUTICS | 16,310 | 0,00 % | Beam Therapeutics Announces U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation Granted to BEAM-101 for the Treatment of Sickle Cell Disease | CAMBRIDGE, Mass., Aug. 14, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that... ► Artikel lesen | |
| DYNE THERAPEUTICS | 13,500 | 0,00 % | Dyne Therapeutics, Inc.: Dyne Therapeutics Announces FDA Breakthrough Therapy Designation for DYNE-251 in Duchenne Muscular Dystrophy (DMD) | - Data from the DELIVER registrational expansion cohort is expected in late 2025, with a potential BLA submission for U.S. accelerated approval anticipated in early 2026 - WALTHAM, Mass., Aug.... ► Artikel lesen |
BPC INSTRUMENTS AB gehört der Branche Biotechnologie an. Der aktuelle Kurs liegt bei 3,060 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu BPC INSTRUMENTS AB finden Sie auf Wallstreet Online.